imedecin UK tRSSNews
Afficher l'Article
CSL agrees $3bn cash deal for Talecris
Mercredi 13 Août 2008 - 20:17 - 4 mois, 3 semaines depuis - Newspaper & TV news - FT.com - Drugs and Healthcare
CSL has agreed to buy Talecris Biotherapeutics of the US for US$3.1bn in cash, as the Australian pharmaceutical group seeks to consolidate its presence in the global plasma products market.
